$13 million gift launched new maternal and child health center at UC Berkeley’s School of Public Health
On Mar. 2, 2015, Dr. Helen Wallace, a world-renowned professor, mentor and advocate known for her passion for…
-
-
Funding was announced for the TEC Health Accelerator for Alberta, to assist promising startup healthcare companies
On Nov. 21, 2014, funding was announced for the TEC Health Accelerator for Alberta, to assist promising startup…
-
World’s first child born after uterus transplantation
On Oct. 3, 2014, the University of Gothenburg announced that seven Swedish women in a ground-breaking research project…
-
Mary-Claire King received Lasker Foundation Award
On Sept. 8, 2014, the University of Washington and UW Medicine announced that Mary-Claire King, UW professor of…
-
Biotechnology | Chemistry | FDA | Oncology | Therapeutics | Women's Health
FDA approved Genentech’s Avastin plus chemotherapy for treatment of advanced cervical cancer
On Aug. 14. 2014, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Avastin (bevacizumab)…
-
Stanford Medicine researchers found that a gene variant puts women at higher risk of Alzheimer’s than it does men
On Apr. 14, 2014, Stanford Medicine researchers announced a study that found a gene variant puts women at…
-
OHSU announced creation of new embryonic stem cell and gene therapy center
On Mar. 5, 2014, Oregon Health & Science University (OHSU) announced the creation of the Center for Embryonic…
-
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
-
ACIP recommended a dose of Tdap vaccine during each pregnancy
On Feb. 22, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended that unvaccinated pregnant women receive a…
-
ACIP voted to recommend that pregnant women receive a dose of Tdap during each pregnancy
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
-
Hologic acquired Gen-Probe for $37 billion
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
-
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Therapeutics | Women's Health
The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and children
On Apr. 30, 2011, The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers…
-
National Women and Girls HIV/AIDS Awareness Day was established
On Mar. 10, 2010, National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) was established as a nationwide initiative…
-
Siteman Cancer Center received NCI SPORE grant to study endometrial cancer
On Mar. 5, 2010, the National Cancer Institute (NCI) announced that it had awarded the Siteman Cancer Center…
-
FDA approved Cervarix, GlaxoSmithKline’s cervical cancer vaccine
On Oct. 16, 2009, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Cervarix [Human papillomavirus…
-
OHSU Cancer Institute received $5 million gift to establish state-of-the-art research laboratories
On Feb. 20, 2008, Lori and Jen-Hsun Huang of Los Altos Hills, California, announced a $5 million gift…
-
Evestra was spun-off as a private company from the Texas Biomed Department of Organic Chemistry
In 2008, Evestra was spun-off as a private biopharmaceutical company from the Texas Biomed Department of Organic Chemistry….
-
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics | Women's Health
Seattle Cancer Care Alliance introduced the Mammovan, making digital mammography more accessible
In 2008, the Seattle Cancer Care Alliance introduced the Mammovan, making digital mammography more accessible to women throughout…
-
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Breast Cancer Research Stamp Reauthorization Act extended through December 31, 2011
On Dec. 12, 2007, the Breast Cancer Research Stamp Reauthorization Act extended through Dec. 31, 2011, provisions requiring…
-
National Cancer Institute developed more accurate method of estimating invasive breast cancer risk in African americans
On Nov. 27, 2007, a new National Cancer Institute (NCI) model for calculating invasive breast cancer risk, called…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved Eli Lilly and Company’s osteoporosis drug, Evista, to reduce the risk of invasive breast cancer
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
-
National Breast and Cervical Cancer Act allowed states federal waivers to spend a greater share of funds on underserved women
On Apr. 20, 2007, the National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 allowed…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
Decrease in breast cancer rates related to reduction in use of hormone replacement therapy
On Apr. 18, 2007, a study led by the University of Texas M.D. Anderson Cancer Center reported that…
-
MRI detected cancers in the opposite breast of women newly diagnosed with breast cancer
On Mar. 28, 2007, Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics | Women's Health
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
-
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
-
Personalized treatment trial for breast cancer was launched
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…
-
Osteoporosis drug shown to be as effective as Tamoxifen in preventing invasive breast cancer
On Apr. 17, 2006, the National Cancer Institute (NCI) announced initial results of the Study of Tamoxifen and…
